Surgery Gross Profit from 2010 to 2024

SGRY Stock

USD 23.01 0.34 1.46%

Surgery Partners Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 377.3 M in 2024. Gross Profit is the profit Surgery Partners makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2013-12-31

Previous Quarter

179.2 M

Current Value

177.5 M

Quarterly Volatility

39.5 M

Yuan Drop

Covid

Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.

Check out the analysis of Surgery Partners Correlation against competitors.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Surgery Partners over the last few years. Gross profit is a required income statement account that reflects total revenue of Surgery Partners minus its cost of goods sold. It is profit before Surgery Partners operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Surgery Partners' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 574.9 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Surgery Gross Profit Regression Statistics

	Arithmetic Mean	313,023,348
	Geometric Mean	263,221,707
	Coefficient Of Variation	52.60
	Mean Deviation	136,146,945
	Median	327,419,000
	Standard Deviation	164,649,997
	Sample Variance	27109.6T
	Range	474M
	R-Value	0.91
	Mean Square Error	4778.3T
	R-Squared	0.84
	Slope	33,669,434
	Total Sum of Squares	379534.7T

Surgery Gross Profit History

	2024	377.3 M
	2023	529.4 M
	2022	574.9 M
	2021	491.4 M
	2020	379.8 M
	2019	423.8 M
	2018	410 M

Other Fundumenentals of Surgery Partners

Gross Profit Margin

Surgery Partners Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Common Stock	Short Term Investments	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.77	0.97	-0.71	0.97	0.98	0.99	1.0	0.93	0.98	0.97	0.63	0.89	-0.02	-0.11	0.87	0.97	0.68	0.38	0.96	0.72	0.35	0.45	-0.62
Total Stockholder Equity	0.77		0.66	-0.75	0.84	0.66	0.78	0.74	0.64	0.77	0.72	0.38	0.9	0.13	0.2	0.87	0.76	0.86	-0.05	0.73	0.98	0.52	0.72	-0.91
Net Debt	0.97	0.66		-0.71	0.92	1.0	0.97	0.98	0.94	0.95	0.97	0.68	0.87	-0.06	-0.15	0.77	0.94	0.55	0.51	0.95	0.62	0.26	0.3	-0.5
Retained Earnings	-0.71	-0.75	-0.71		-0.78	-0.69	-0.77	-0.66	-0.6	-0.77	-0.74	-0.37	-0.86	-0.33	-0.38	-0.73	-0.61	-0.76	-0.16	-0.66	-0.8	-0.4	-0.62	0.78
Accounts Payable	0.97	0.84	0.92	-0.78		0.91	0.98	0.96	0.85	0.96	0.95	0.56	0.92	0.05	0.01	0.94	0.94	0.83	0.25	0.92	0.81	0.46	0.56	-0.72
Long Term Debt	0.98	0.66	1.0	-0.69	0.91		0.97	0.98	0.95	0.96	0.96	0.7	0.85	-0.04	-0.15	0.75	0.94	0.54	0.48	0.95	0.62	0.23	0.32	-0.5
Net Receivables	0.99	0.78	0.97	-0.77	0.98	0.97		0.98	0.91	0.99	0.96	0.64	0.9	0.04	-0.07	0.87	0.95	0.72	0.33	0.94	0.74	0.36	0.49	-0.64
Good Will	1.0	0.74	0.98	-0.66	0.96	0.98	0.98		0.94	0.97	0.96	0.67	0.87	-0.07	-0.17	0.84	0.97	0.63	0.41	0.96	0.69	0.32	0.39	-0.57
Total Liab	0.93	0.64	0.94	-0.6	0.85	0.95	0.91	0.94		0.92	0.9	0.57	0.79	-0.02	-0.24	0.72	0.89	0.47	0.45	0.9	0.56	0.16	0.35	-0.48
Total Current Assets	0.98	0.77	0.95	-0.77	0.96	0.96	0.99	0.97	0.92		0.96	0.59	0.88	0.13	0.01	0.84	0.94	0.7	0.31	0.94	0.72	0.28	0.56	-0.66
Short Term Debt	0.97	0.72	0.97	-0.74	0.95	0.96	0.96	0.96	0.9	0.96		0.52	0.91	0.01	-0.01	0.85	0.96	0.66	0.45	0.97	0.69	0.35	0.38	-0.57
Intangible Assets	0.63	0.38	0.68	-0.37	0.56	0.7	0.64	0.67	0.57	0.59	0.52		0.49	-0.26	-0.37	0.37	0.57	0.21	0.23	0.51	0.34	0.18	0.05	-0.2
Property Plant Equipment	0.89	0.9	0.87	-0.86	0.92	0.85	0.9	0.87	0.79	0.88	0.91	0.49		0.05	0.18	0.87	0.88	0.75	0.28	0.89	0.91	0.47	0.52	-0.78
Net Tangible Assets	-0.02	0.13	-0.06	-0.33	0.05	-0.04	0.04	-0.07	-0.02	0.13	0.01	-0.26	0.05		0.5	-0.05	-0.13	0.28	-0.53	-0.03	0.17	-0.48	0.66	-0.49
Current Deferred Revenue	-0.11	0.2	-0.15	-0.38	0.01	-0.15	-0.07	-0.17	-0.24	0.01	-0.01	-0.37	0.18	0.5		0.09	-0.08	0.32	-0.3	-0.02	0.33	0.13	0.51	-0.39
Long Term Investments	0.87	0.87	0.77	-0.73	0.94	0.75	0.87	0.84	0.72	0.84	0.85	0.37	0.87	-0.05	0.09		0.85	0.9	0.18	0.81	0.85	0.68	0.59	-0.73
Short Long Term Debt	0.97	0.76	0.94	-0.61	0.94	0.94	0.95	0.97	0.89	0.94	0.96	0.57	0.88	-0.13	-0.08	0.85		0.63	0.44	0.98	0.7	0.37	0.37	-0.55
Common Stock	0.68	0.86	0.55	-0.76	0.83	0.54	0.72	0.63	0.47	0.7	0.66	0.21	0.75	0.28	0.32	0.9	0.63		-0.17	0.61	0.86	0.58	0.79	-0.87
Short Term Investments	0.38	-0.05	0.51	-0.16	0.25	0.48	0.33	0.41	0.45	0.31	0.45	0.23	0.28	-0.53	-0.3	0.18	0.44	-0.17		0.49	-0.05	0.09	-0.47	0.26
Long Term Debt Total	0.96	0.73	0.95	-0.66	0.92	0.95	0.94	0.96	0.9	0.94	0.97	0.51	0.89	-0.03	-0.02	0.81	0.98	0.61	0.49		0.7	0.27	0.37	-0.58
Capital Surpluse	0.72	0.98	0.62	-0.8	0.81	0.62	0.74	0.69	0.56	0.72	0.69	0.34	0.91	0.17	0.33	0.85	0.7	0.86	-0.05	0.7		0.53	0.72	-0.93
Net Invested Capital	0.35	0.52	0.26	-0.4	0.46	0.23	0.36	0.32	0.16	0.28	0.35	0.18	0.47	-0.48	0.13	0.68	0.37	0.58	0.09	0.27	0.53		0.18	-0.29
Net Working Capital	0.45	0.72	0.3	-0.62	0.56	0.32	0.49	0.39	0.35	0.56	0.38	0.05	0.52	0.66	0.51	0.59	0.37	0.79	-0.47	0.37	0.72	0.18		-0.87
Capital Stock	-0.62	-0.91	-0.5	0.78	-0.72	-0.5	-0.64	-0.57	-0.48	-0.66	-0.57	-0.2	-0.78	-0.49	-0.39	-0.73	-0.55	-0.87	0.26	-0.58	-0.93	-0.29	-0.87

Click cells to compare fundamentals

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	529.4 M	377.3 M
Gross Profit Margin	0.19	0.30

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC